Ozempic and Wegovy are typically started at 0.25 mg once weekly for the first month, then increased gradually from there to a maintenance dose of up to 2 mg for Ozempic and 2.4 mg for Wegovy
Known as the body's master antioxidant, glutathione works from within to neutralise free radicals, support detoxification, and reduce excess melanin productionmaking it a popular choice for those looking to combat hyperpigmentation, dullness, and premature ageing
The potential neuroprotective properties of GLP-1R agonists have also been demonstrated in clinical trials, with Novo Nordisk currently running a phase III clinical trial of oral semaglutide as a potential treatment option for Alzheimers disease in the announced EVOKE trial program (NCT04777409, NCT04777396)
However, acylcarnitine was shown to reduce the levels of specific claudin proteins and alter the barrier function of tight junctions in Caco-2 cell monolayers and is should be cautiously considered for people who already have intestinal barrier problems [237]